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Abstract We have transferred the prokaryotic QN resolvase
system to mammalian cells and present a comparative analysis of
recombination by wild-type and two mutant resolvases (E124Q
and E102Y/E124Q). Transient co-transfection assays using L-
galactosidase as reporter for recombination reveal that episomal
DNA does not contain a significant level of unconstrained
negative supercoiling, since only mutant resolvases are recombi-
nation-proficient. We also show that the efficiency of recombina-
tion by the resolvase double mutant is comparable to that
observed with Cre, which indicates that resolvase can be used as a
new tool for controlled manipulations of episomal DNAs.
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1. Introduction
The bacterial QN (Tn1000) transposon-encoded resolvase be-
longs to the resolvase/invertase sub-family of conservative
site-speci¢c DNA recombinases. Its natural function is to re-
solve, through recombination, the co-integrate structure that
is generated during transposition [1]. Resolvase recognizes a
114 bp DNA segment called res, which is composed of three
binding sites (I^III) for resolvase dimers. Two res must be
present as direct repeats on the same negatively (3) super-
coiled DNA molecule. Only this orientation of sites allows
for the formation of a functional synaptic complex, the so-
called synaptosome, which entraps three (3) supercoils [2].
Intramolecular recombination catalyzed within the synapto-
some thus results in excision of the DNA segment between
res sites.
An important prerequisite for e⁄cient recombination by
wild-type resolvase in Escherichia coli and in vitro is the pres-
ence of unconstrained (3) supercoiling in the substrate.
Supercoiling is required for the assembly of a functional syn-
aptosome and, in addition, energetically drives the DNA
strand exchange reaction once the DNA has been cleaved at
sub-binding sites I of the paired res [3]. We have transferred
the resolvase system to mammalian cells and employ in this
study wild-type and two QN resolvase mutants, E124Q and
double mutant E102Y/E124Q. Both mutants are homologs
of two previously characterized Tn3 resolvase mutants and
exhibit the same phenotype, i.e. they e⁄ciently perform re-
combination in vitro on topologically relaxed DNA substrates
containing two copies of res [4]. The double mutant, in addi-
tion, is pro¢cient at catalyzing recombination on substrates
containing two isolated I sites of res as direct or inverted
repeats. However, the e⁄ciency of the latter reaction is still
signi¢cantly enhanced by (3) supercoiling of the substrate [4].
A comparative study of recombination by wild-type and mu-
tant resolvase inside mammalian cells should therefore help to
further elucidate the topological state of episomal and, even-
tually, genomic DNA.
2. Materials and methods
2.1. Expression and substrate vectors
Expression vectors for wild-type and mutant resolvases are deriva-
tives of pPGKCre (K. Fellenberg, University of Cologne). The resol-
vase genes were cloned by PCR using primers (P-QNA) 5P-GATACTG-
CAGCATGCGACTTTTTGGTTACGCACGGGTATCA-3P, (P-QNB)
5P-GATATCTAGATTAGTTGCTTTCATTTATTACTTTATA-3P,
(P-QN124Q) 5P-CGACAGAGAATACTACAGCGTACCAATGAA-
3P, (P-QN124Qanti) 5P-TTCATTGGTACGCTGTAGTATTCTCTGT-
CG-3P, (P-QN102Y) 5P-AGTACCGATGGGTATATGGGTAAAAT-
GGTT-3P, (P-QN102Yanti) 5P-AACCATTTTACCCATATACCCAT-
CGGTACT-3P, and (P-2972) 5P-CATATCTAGACTATTAAAC-
CTTCCTCTTCTTCTTAGGGTTGCTTTCATTTATTACTTTATA-
3P. Wild-type resolvase was generated with primers P-QNA and P-QNB,
and DNA isolated from E. coli strain DH5K, which contains the QN
transposon on the FP plasmid, served as template. The nuclear local-
ization signal (NLS) variant (pPGKQNNLS) was generated using P-
2972 instead of P-QNB. The resulting PCR fragments replaced the Cre
gene in pPGKCre, using XbaI and PstI. pPGKQN124 was generated by
assembly PCR using P-QNA and P-QN124Qanti, as well as P-QNB and P-
QN124Q as primer pairs. pPGKQN served as template. pPGKQN102 was
also generated by assembly PCR using P-QNA and P-QN102Y, as well
as P-QNB and P-QN102Yanti as primer pairs. pPGKQN124 served as
template. The corresponding NLS-carrying variants were generated
as described for pPGKQNNLS.
Substrate vectors are derivatives of pCH110 (Pharmacia). First, the
prokaryotic promoter driving the lacZ gene in pCH110 was deleted by
PCR and the lacZ gene was re-inserted. The neomycin gene was iso-
lated from pSV2Neo [5] using SmaI and BglII, and subsequently
£anked by two res sites which were generated by PCR employing
pZWX1 [6] as template. After ligation, the res-neo-res cassette was
cleaved with HindIII and inserted between the SV40 promoter and the
lacZ gene of the modi¢ed pCH110 vector. The promoter proximal to
res was modi¢ed at two residues in order to eliminate two ATGs, thus
generating pCH-RNRZ. pCH-SNSZ and pCH-RLNRLZ are deriva-
tives of pCH-RNRZ, and were generated by PCR. The corresponding
recombined product vectors of pCH-RNRZ and pCH-RLNRLZ were
generated through transformation into DH5K or 294-Cre [7], respec-
tively. pCH-SZ was generated by PCR.
Plasmid DNAs were isolated from E. coli strains JC5547,
BMH8117, DH5K or 294-Cre using a⁄nity chromatography (Qiagen,
Germany). Expression and substrate vectors were sequenced using the
£uorescence-based 373A system (Applied Biosystems). PCRs were
usually performed with 30 cycles using the ‘Master MixQ Kit’ (Qia-
gen, Germany). The reaction temperatures were calculated based on
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the respective primer sequences and the length of the expected prod-
uct.
2.2. Cell culture and in vivo recombination assays
Transient resolvase expression and recombination assays employed
CHO cells cultured in Dulbecco’s modi¢ed Eagle’s medium containing
10% fetal calf serum, 2 mM L-glutamine, streptomycin (0.1 mg/ml),
and penicillin (100 U/ml). Transient co-transfection assays were per-
formed with supercoiled expression and substrate vectors at a molar
ratio of about 3:1 and lipofection (FuGene16; Boehringer Mann-
heim, Germany). About 2U105 cells were transfected with 2 Wg of
mixed plasmid DNA. Transfection e⁄ciencies were usually in the
range of 20^30%. Cells were analyzed 72 h post transfection by either
cell staining or determining the L-galactosidase activity (L-gal).
2.3. L-Gal assays
Cells were stained after ¢xation with 0.5% (w/v) glutaraldehyde
through incubation with a solution made up of 5 mM
K3Fe(Cn)6W3H2O, 2 mM MgCl2, and 4 mg/ml X-Gal in phosphate-
bu¡ered saline. The number of stained cells was determined micro-
scopically after 7^8 h of incubation at 37‡C. L-Gal activity was de-
termined in cell lysates using the Galacto Light Kit (Tropix, Perkin
Elmer), as recommended by the manufacturer. Relative light units
(RLU) were determined in a Lumat LB9501 luminometer (Berthold),
and normalized to the amount of protein (Wg) in each lysate deter-
mined by the Bio-Rad protein assay.
2.4. Immunoblotting
Cell lysates from transiently transfected cells were prepared by boil-
ing the harvested cells in sample bu¡er for 5 min. Proteins were
separated through 12.5% SDS polyacrylamide gels and transferred
onto a nitrocellulose membrane (Immobilon P, Millipore). The mem-
brane was blocked with 1% blocking solution and incubated with
mouse polyclonal antibodies raised against wild-type resolvase at a
1:3000 dilution. Peroxidase-conjugated secondary antibodies were
used for detection (Boehringer Mannheim, Germany). Puri¢ed resol-
vase was used as a control [6].
3. Results
3.1. Expression of wild-type and mutant resolvases in CHO
cells
We constructed eukaryotic expression vectors which con-
tain the coding region for wild-type or mutant resolvase under
the control of the phosphoglycerate kinase promoter (PGK).
Two sets of vectors were generated: one containing an NLS
and a corresponding set (Fig. 1A) lacking one fused to the C-
terminal end of resolvase genes. At 72 h post transfection into
CHO cells, we could detect resolvase by Western blotting us-
ing mouse polyclonal antibodies raised against wild-type re-
solvase (Fig. 2, lanes 3^8). The parental expression vector
(pPGKCre) containing the Cre gene (lane 1) and puri¢ed
resolvase (lane 2) served as controls. The results also show
that the presence of the NLS has a profound e¡ect on the
amount of resolvase detectable in cell lysates (lanes 4, 6, and
8). However, the amount of each resolvase variant generated
from the same set of expression vectors seems to be compa-
rable. Identical results were obtained after transfection into
HeLa and NIH3T3 cells (data not shown). We conclude
that presumably full-length resolvase protein is produced by
di¡erent cell lines.
3.2. Only mutant resolvases are recombination-pro¢cient
In order to test whether wild-type and/or mutant resolvase
can perform recombination in CHO cells, we constructed a
substrate plasmid termed pCH-RNRZ (Fig. 1B). This vector
contains two res as direct repeats £anking the neomycin re-
sistance gene (neo). This recombination cassette, in turn, is
£anked by the SV40 promoter (SV40) and the lacZ gene.
Hence, recombination between res should lead to deletion of
the neo gene and the subsequent expression of L-gal.
We introduced pCH-RNRZ together with each of the six
expression vectors for resolvase into CHO cells. Cell extracts
were prepared 72 h after transfection and recombination was
monitored by determining the normalized L-gal activity. As a
control to determine the highest achievable level, set at 100%,
we co-transfected the recombined product vector pCH-RZ
with pPGKCre. The results (Fig. 3A) show that cells express-
ing mutant resolvase, either with or without NLS, exhibit
about 60% L-gal activity. This level is even higher (about
80%) when compared to a second control, i.e. pCH-RZ co-
transfected with the expression vector for the double mutant,
pPGKQN102. In contrast, cells co-transfected with pPGKQN or
pPGKQNNLS and pCH-RNRZ exhibit only negligible L-gal
activity (5%). This low level is comparable to two other
controls : the substrate pCH-RNRZ co-transfected with
pPGKCre, and pPGKQN102 transfected alone.
Fig. 1. Resolvase expression and substrate vectors. A: Relevant ge-
netic elements present on expression vectors for Cre, wild-type or
two mutant resolvases are schematized. A corresponding second set
of vectors for resolvase, labelled with the postscript NLS, carries a
SV40 large tumor antigen NLS fused to the C-terminal end of resol-
vase (not shown). B: Standard substrate for resolvase. C: Standard
substrate for both resolvase and Cre. The orientation of recombina-
tion sites is indicated by arrows. The positions of resolvase sub-
binding sites within res are demarcated by black rectangles and la-
belled I^III. See text for details.
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We also determined the fraction of X-gal-stained cells 72 h
after co-transfection of substrate and expression vectors. The
result of a representative experiment (Table 1) reveals that
both mutants generate a signi¢cant fraction of stained cells
if compared again to the control employing the recombined
substrate (pCH-RZ), set at 100%. However, this fraction is
rather low and comparable to a negative control (pPGKCre)
when either pPGKQN or pPGKQNNLS was used. We conclude
that within the limits of detection by these methods both mu-
tant resolvases, but not the wild-type, catalyze recombination
on episomal substrates in mammalian cells.
3.3. Recombination on isolated I sites of res
We were interested to test whether mutant resolvases can
recombine two copies of isolated I sites of res. We therefore
constructed pCH-SNSZ, which is identical to pCH-RNRZ
except that sub-sites II and III of each res are deleted (com-
pare Fig. 1B). Recombination assays employing the corre-
sponding product vector pCH-SZ and pPGKCre as control
(100%) were performed as described above. The results show
(Fig. 3B) that only the resolvase double mutant recombines
this substrate in CHO cells. However, the e⁄ciency of this
reaction is signi¢cantly reduced compared to recombination
on pCH-RNRZ.
3.4. Cre and the resolvase double mutant exhibit comparable
activities
In order to compare the recombination e⁄ciency of the
resolvase double mutant with that of Cre, we generated
pCH-RLNRLZ. This substrate is identical to pCH-RNRZ,
but contains in addition two recombination sites (lox) for
Cre as direct repeats also £anking the neo gene (Fig. 1C).
Hence, recombination by either resolvase or Cre deletes the
neo gene and results in the subsequent expression of the lacZ
gene. Co-transfections were performed with pPGKQN102NLS
and pPGKCre as described above. The corresponding recom-
bined product vector was used in each case as control (100%).
Fig. 2. Western analysis. Wild-type and mutant resolvases expressed
in CHO cells. The higher and lower arrows point to the position of
resolvase with and without an NLS, respectively.
Fig. 3. Analysis of recombination by L-gal assays. A: Recombina-
tion on pCH-RNRZ containing two complete res. B: Recombina-
tion on pCH-SNSZ containing two isolated copies of I sites of res.
C: Recombination on pCH-RLNRLZ containing res and lox sites.
As an additional control, in C we used an expression vector for a
phage V integrase mutant, Int-h, co-transfected with pCH-RLNRLZ
[11]. In each case, data were collected from four to six separate
transfections assays each employing between two and four wells
containing about 2U105 CHO cells. The graphs show the mean val-
ues with standard deviations indicated by vertical lines. See text for
details.
Table 1
Recombination analyzed by cell staining
Co-transfected plasmids Stained cells (%)
None 0
pCH-RZ+pPGKQN102NLS 100
pCH-RNRZ+pPGKCre 9
pCH-RNRZ+pPGKQN 4
pCH-RNRZ+pPGKQNNLS 11
pCH-RNRZ+pPGKQN124NLS 44
pCH-RNRZ+pPGKQN102NLS 96
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The results show that the double mutant is at least as e⁄cient
as Cre at performing recombination on episomal substrates
(Fig. 3C).
4. Discussion
We have demonstrated that two mutant QN resolvases can
catalyze intramolecular recombination on episomal res inside
mammalian cells. Recombination by wild-type resolvase, how-
ever, is not detectable. Based on the fact that only mutant
resolvases recombine topologically relaxed substrates [4], a
major conclusion is that episomal DNA does not contain a
signi¢cant level of unconstrained (3) supercoiling over at least
the time course of the experiment. This interpretation is sup-
ported by the result that only the double mutant recombines a
substrate containing isolated I sites of res, albeit with a sig-
ni¢cantly reduced e⁄ciency compared to recombination on a
standard substrate.
Since we used (3) supercoiled plasmids for co-transfection,
a second conclusion is that plasmid supercoiling must be re-
laxed once the DNA is introduced to the cells. This could be
due to the action of topoisomerases [8] and/or the formation
of nucleosomes on the internalized plasmids, a process which
would consume unconstrained (3) supercoils. However, based
on a topological analysis of plasmid DNA isolated from CHO
cells 72 h post transfection, we found no evidence for nucle-
osome formation, i.e. the plasmid DNA was topologically
relaxed (data not shown). Future comparative studies employ-
ing wild-type and mutant resolvase in reporter cell lines
should also help to elucidate the topological state of genomic
target sites and how it might be a¡ected by, for example,
transcription and the in£uence of topoisomerase or histone
acetylase inhibitors [8,9].
A third conclusion from our study is that the resolvase
double mutant performs recombination on episomal sub-
strates with an e⁄ciency comparable to that of Cre. The latter
recombinase is used widely in studies elucidating the relevance
and function of particular genes of interest in animal model
systems [10]. If recombination by the resolvase double mutant
is also e⁄cient on genomic target sites, the available possibil-
ities for controlled in vivo and ex vivo manipulations of eu-
karyotic genomes will be expanded.
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